U.S. Scientists Are Enrolling Nearly 40,000 Patients in 4-Year $1.2 Billion Study of Long Covid
The study, Recover, aims to complete enrollment of 40,000 people and launch clinical trials on potential treatments by the end of the year.
Stay updated with breaking news from Led Research Collaborative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study, Recover, aims to complete enrollment of 40,000 people and launch clinical trials on potential treatments by the end of the year.
The study, Recover, aims to complete enrollment of 40,000 people and launch clinical trials on potential treatments by the end of the year.
After analysing a symptom-tracking app, researchers found 4.5 per cent of users who were infected when the omicron variant was dominant had symptoms at least four weeks later, compared with 10.8 per cent of the users who probably caught delta
Long COVID emerges as a mass-disabling event, with millions suffering prolonged effects and vying for limited resources.
The dramatic influx of newly disabled Americans changes the calculus for disability advocates. Read more at Boston.com.